How much funding has COMPASS Pathways raised?

COMPASS Pathways has raised $972.0M in total funding, most recently a Venture Round.

Who are COMPASS Pathways's investors?

COMPASS Pathways's investors include Peter Thiel, ATAI Life Sciences, Christian Angermayer, Mike Novogratz.

When was COMPASS Pathways founded?

COMPASS Pathways was founded in 2016.

Where is COMPASS Pathways headquartered?

COMPASS Pathways is headquartered in London, England, United Kingdom.

What industry is COMPASS Pathways in?

COMPASS Pathways operates in Healthcare, Mental Health.

How many employees does COMPASS Pathways have?

COMPASS Pathways has 51-200 employees.

COMPASS Pathways

IPO

We connect science and compassion to reimagine mental health care.

London, United Kingdom · Founded 2016 · $972.0M raised

Healthcare

Mental Health

Headquarters: London, England
Employees: 51–200
Founded: 2016
Business Model: B2B

Website: compasspathways.com
Total Funding: $972.0M
Last Round: $200.0M Venture RoundFeb 2026
Rounds: 9

About

COMPASS Pathways is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is developing COMP360 psilocybin therapy, currently in Phase 3 clinical trials for treatment-resistant depression, as well as studies for PTSD and anorexia nervosa. Listed on Nasdaq as CMPS, COMPASS holds FDA Breakthrough Therapy designation for its lead candidate.

Summary

COMPASS Pathways is a Healthcare company based in London, United Kingdom, founded in 2016. It has raised $972.0M in total across 9 rounds, most recently a $200.0M Venture Round round in Feb 2026. Investors include Peter Thiel, ATAI Life Sciences and Christian Angermayer.

LinkedIn X (Twitter)